2 assets in Plexiform Neurofibroma

Therapeutic assets addressing Plexiform Neurofibroma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Avutometinib Plexiform Neurofibroma	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Turalio Plexiform Neurofibroma	National Cancer Institute (NCI)	P1	NR ()